Magnetic Human Corneal Endothelial Cells
Cell therapyexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 4, 2016 (NCT04191629)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06726174 | Phase 1 | Feb 28, 2025 | National Taiwan University |
| NCT05636579 | Phase 1 | Dec 1, 2022 | Asociación para Evitar la Ceguera en México, Emmecell |
| NCT05587205 | Phase 1 | Dec 1, 2022 | Asociación para Evitar la Ceguera en México, Emmecell |
| NCT04894110 | Phase 1 | Jun 22, 2021 | Emmecell |
| NCT04191629 | Phase 1 | May 4, 2016 | Asociación para Evitar la Ceguera en México, Emmecell |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Emmecell | For profit | 4 | 1 | 1 | 2016 |
| Asociación para Evitar la Ceguera en México | Academic/Hospital | 3 | 3 | 1 | 2016 |
| National Taiwan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1